撤回通知：“巴氯芬与托哌酮治疗脊髓损伤所致痉挛的临床疗效与安全性的比较研究”[《沙特药学杂志》25 (2017) 655 - 659]
Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].
作者信息
Luo Dejun, Wu Guoyong, Ji Yong, Zhang Zhaoyao, He Fayou, Mou Xiaping, Zhu Qingmao, Yang Bo
机构信息
Department of Orthopedics, Jianyang People's Hospital of Sichuan, Jianyang 641400, China.
出版信息
Saudi Pharm J. 2020 May;28(5):639. doi: 10.1016/j.jsps.2020.02.014. Epub 2020 May 12.
Abstract
[This retracts the article DOI: 10.1016/j.jsps.2017.04.041.].
摘要
[本文撤回文章DOI: 10.1016/j.jsps.2017.04.041。]
相似文献
1
Retraction notice to "The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury" [Saudi Pharm. J. 25 (2017) 655-659].
Saudi Pharm J. 2020 May;28(5):639. doi: 10.1016/j.jsps.2020.02.014. Epub 2020 May 12.
2
Retraction notice to "Melatonin alleviates acute spinal cord injury in rats through promoting on progenitor cells proliferation" [Saudi Pharm. J. 25 (2017) 570-574].
Saudi Pharm J. 2020 May;28(5):638. doi: 10.1016/j.jsps.2020.02.013. Epub 2020 May 12.
3
Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
Biomed Pharmacother. 2017 Mar;87:628-635. doi: 10.1016/j.biopha.2017.01.005. Epub 2017 Jan 10.
4
The comparative study of clinical efficacy and safety of baclofen vs tolperisone in spasticity caused by spinal cord injury.
Saudi Pharm J. 2017 May;25(4):655-659. doi: 10.1016/j.jsps.2017.04.041. Epub 2017 May 7.
5
Retraction notice to "The influence of connective tissue growth factor on rabbit ligament injury repair" [Saudi Pharm. J. 25 (2017) 498-503].
Saudi Pharm J. 2020 May;28(5):637. doi: 10.1016/j.jsps.2020.02.012. Epub 2020 May 12.
6
Retraction notice to "Biomedical microelectromechanical systems (BioMEMS): Revolution in drug delivery and analytical techniques" [Saudi Pharm. J. 24 (2016) 1-20].
Saudi Pharm J. 2019 Mar;27(3):453. doi: 10.1016/j.jsps.2019.03.003. Epub 2019 Mar 13.
7
Retraction notice to "The cytoprotective effects of Δ-17 fatty acid desaturase on injured HUVECs and its underlying mechanism" [Saudi Pharm. J. 25(4) (2017) 587-594].
Saudi Pharm J. 2022 May;30(5):647. doi: 10.1016/j.jsps.2022.04.010. Epub 2022 May 11.
8
Retraction notice to "Pulmonary route of administration is instrumental in developing therapeutic interventions against respiratory diseases" [Saudi Pharm. J. 28(12) (2020) 1655-1665].
Saudi Pharm J. 2022 May;30(5):646. doi: 10.1016/j.jsps.2022.04.011. Epub 2022 May 11.
9
Retraction notice to "Protective effect of Huangpu Tongqiao capsule against Alzheimer's disease through inhibiting the apoptosis pathway mediated by endoplasmic reticulum stress and " [Saudi Pharm. J. 30(11) (2022) 1561-1571].
Saudi Pharm J. 2024 Nov;32(11):102183. doi: 10.1016/j.jsps.2024.102183. Epub 2024 Sep 21.
10
Efficacy and Safety of Botulinum Toxin Type A in Spasticity Caused by Spinal Cord Injury: A Randomized, Controlled Trial.
Med Sci Monit. 2018 Nov 13;24:8160-8171. doi: 10.12659/MSM.911296.
Zotero 插件